Literature DB >> 30426678

Age-related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age.

Timothy P O'Leary1, Hector M Mantolino1, Kurt R Stover1, Richard E Brown1.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that leads to age-related cognitive and sensori-motor dysfunction. There is an increased understanding that motor dysfunction contributes to overall AD severity, and a need to ameliorate these impairments. The 5xFAD mouse develops the neuropathology, cognitive and motor impairments observed in AD, and thus may be a valuable animal model to study motor deficits in AD. Therefore, we assessed age-related changes in motor ability of male and female 5xFAD mice from 3 to 16 months of age, using a battery of behavioral tests. At 9-10 months, 5xFAD mice showed reduced body weight, reduced rearing in the open-field and impaired performance on the rotarod compared to wild-type controls. At 12-13 months, 5xFAD mice showed reduced locomotor activity on the open-field, and impaired balance on the balance beam. At 15-16 months, impairments were also seen in grip strength. Although sex differences were observed at specific ages, the development of motor dysfunction was similar in male and female mice. Given the 5xFAD mouse is commonly on a C57BL/6 × SJL hybrid background, a subset of mice may be homozygous recessive for the Dysf im mutant allele, which leads to muscular weakness in SJL mice and may exacerbate motor dysfunction. We found small effects of Dysf im on motor function, suggesting that Dysf im contributes little to motor dysfunction in 5xFAD mice. We conclude that the 5xFAD mouse may be a useful model to study mechanisms that produce motor dysfunction in AD, and to assess the efficacy of therapeutics on ameliorating motor impairment.
© 2018 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  5xFAD; Alzheimer's disease; age-related changes; dysferlin; locomotor activity; mice; motor behavior; motor dysfunction; motor learning and coordination; mouse model

Mesh:

Year:  2018        PMID: 30426678     DOI: 10.1111/gbb.12538

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  15 in total

1.  Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice.

Authors:  Liuji Chen; Nawab John Dar; Ren Na; Kirsten Danae McLane; Kwangsun Yoo; Xianlin Han; Qitao Ran
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

2.  Alterations in odor hedonics in the 5XFAD Alzheimer's disease mouse model and the influence of sex.

Authors:  Elizabeth R Roberts; Amanda M Dossat; María Del Mar Cortijo; Patrik Brundin; Daniel W Wesson
Journal:  Behav Neurosci       Date:  2020-08-06       Impact factor: 1.912

3.  Disruption of metabolic, sleep, and sensorimotor functional outcomes in a female transgenic mouse model of Alzheimer's disease.

Authors:  Divine C Nwafor; Sreeparna Chakraborty; Sujung Jun; Allison L Brichacek; Margaret Dransfeld; Darren E Gemoets; Duaa Dakhlallah; Candice M Brown
Journal:  Behav Brain Res       Date:  2020-11-01       Impact factor: 3.332

4.  Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer's and vascular disease.

Authors:  Tina Wahle; Adriana Sofranko; Susan Dekkers; Mark R Miller; Harm J Heusinkveld; Catrin Albrecht; Flemming R Cassee; Roel P F Schins
Journal:  Neurochem Int       Date:  2020-05-15       Impact factor: 3.921

5.  Pharmacological intervention in a transgenic mouse model improves Alzheimer's-associated pathological phenotype: Involvement of proteasome activation.

Authors:  Aleksandra N Mladenovic Djordjevic; Marianna Kapetanou; Natasa Loncarevic-Vasiljkovic; Smilja Todorovic; Sofia Athanasopoulou; Milena Jovic; Milica Prvulovic; Era Taoufik; Rebecca Matsas; Selma Kanazir; Efstathios S Gonos
Journal:  Free Radic Biol Med       Date:  2020-12-03       Impact factor: 7.376

6.  A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.

Authors:  Antonio J López-Gambero; Cristina Rosell-Valle; Dina Medina-Vera; Juan Antonio Navarro; Antonio Vargas; Patricia Rivera; Carlos Sanjuan; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

7.  Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model.

Authors:  Yoichiro Abe; Natsumi Ikegawa; Keitaro Yoshida; Kyosuke Muramatsu; Satoko Hattori; Kenji Kawai; Minetaka Murakami; Takumi Tanaka; Wakami Goda; Motohito Goto; Taichi Yamamoto; Tadafumi Hashimoto; Kaoru Yamada; Terumasa Shibata; Hidemi Misawa; Masaru Mimura; Kenji F Tanaka; Tsuyoshi Miyakawa; Takeshi Iwatsubo; Jun-Ichi Hata; Takako Niikura; Masato Yasui
Journal:  Acta Neuropathol Commun       Date:  2020-05-12       Impact factor: 7.801

8.  Genetic background modifies CNS-mediated sensorimotor decline in the AD-BXD mouse model of genetic diversity in Alzheimer's disease.

Authors:  Kristen M S O'Connell; Andrew R Ouellette; Sarah M Neuner; Amy R Dunn; Catherine C Kaczorowski
Journal:  Genes Brain Behav       Date:  2019-08-19       Impact factor: 3.449

9.  Caffeoylquinic Acids in Centella asiatica Reverse Cognitive Deficits in Male 5XFAD Alzheimer's Disease Model Mice.

Authors:  Donald G Matthews; Maya Caruso; Armando Alcazar Magana; Kirsten M Wright; Claudia S Maier; Jan F Stevens; Nora E Gray; Joseph F Quinn; Amala Soumyanath
Journal:  Nutrients       Date:  2020-11-13       Impact factor: 5.717

10.  Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study.

Authors:  Adrian L Oblak; Peter B Lin; Kevin P Kotredes; Ravi S Pandey; Dylan Garceau; Harriet M Williams; Asli Uyar; Rita O'Rourke; Sarah O'Rourke; Cynthia Ingraham; Daria Bednarczyk; Melisa Belanger; Zackary A Cope; Gabriela J Little; Sean-Paul G Williams; Carl Ash; Adam Bleckert; Tim Ragan; Benjamin A Logsdon; Lara M Mangravite; Stacey J Sukoff Rizzo; Paul R Territo; Gregory W Carter; Gareth R Howell; Michael Sasner; Bruce T Lamb
Journal:  Front Aging Neurosci       Date:  2021-07-23       Impact factor: 5.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.